NCT07578142Not yet recruiting
AcceXible Speech-Based Screening for Depression and Anxiety in University Students (UAQ, Mexico)
Validación Del Sistema de Cribaje y de Seguimiento de Accexible Para depresión y Ansiedad en el Entorno Del Alumnado de la Universidad Autónoma de Querétaro
Source: ClinicalTrials.gov · Last updated 11 May 2026
Brief summary (registry, in English)
Major depressive disorder (MDD) and anxiety are increasingly prevalent among university student populations, yet early detection remains reliant on psychometric instruments tied to diagnostic criteria (e.g., PHQ-9, GAD). Emerging evidence suggests that depression affects both the acoustic properties and content of speech, making speech analysis a promising candidate as a digital biomarker for early screening. This study evaluates the validity of acceXible, a speech-based machine learning platform, for the detection and monitoring of depression and anxiety in the student population of the Universidad Autónoma de Querétaro, Mexico. AcceXible captures spontaneous speech through open-ended interview tasks and applies automated acoustic and linguistic analysis. The primary objective is to evaluate the validity of the acceXible spontaneous speech analysis system for depression and anxiety screening, assessed against the PHQ and GAD scales as reference standards. Secondary objectives include examining associations between speech-derived variables and other study measures, evaluating participant engagement with digital mental health resources, assessing user satisfaction with the platform, and analyzing longitudinal changes in scores across follow-up assessments.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 80 (estimated)
- First submitted
- 5 May 2026
- Start date
- 5 Sept 2026
- Primary completion date
- 30 Sept 2027
- Lead sponsor
- Accexible
- Diseases
- Depression
- NCT number
- NCT07578142
What you commit to
- Study type: Observational
- Planned participants: 80
- From 5 Sept 2026 to the primary completion date, 30 Sept 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Sensory impairment (visual or auditory)
- Cognitive impairment
Other
- Refusal to participate
- Psychomotor agitation
Who the study is looking for
- Provision of voluntary written informed consent
- Age 16-25 years
- Current enrollment at BUAP
- Spanish language proficiency
- Access to a mobile device with internet connectivity
- Ability to understand and follow basic acceXible usage instructions
Age in the registry: 16 years to 25 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Universidad Autónoma de Querétaro Coordinator of this site? Confirm its status | Querétaro City | Mexico | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.